from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3089/fadD13

LFCtreatmentdescriptionclass of inhibitor

-0.566

Amikacinug/mL Amikacintranslation

-0.524

Cap5-10ug/mL Capreomycintranslation

-0.464

Rox10-50 ug/mL Roxithromycintranslation

-0.574

SM2-5 ug/mL Streptomycintranslation

-0.777

Tet5-10 ug/mL Tetracyclinetranslation

-0.553

Rif0.2-5ug/mL Rifampicintranscription

-0.276

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.909

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.338

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.163

CPZ10-50 ug/mL Chlorpromazinerespiration

0.196

Clofazimine10-13 ug/mL Clofaziminerespiration

0.087

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.537

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

2.420

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.304

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.024

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.457

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.252

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.102

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.187

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.192

KCN5-20 ug/mL Potassium cyaniderespiration

0.898

NaN30.2-2 mM Sodium aziderespiration

-0.474

Nigericin50 uM Nigericinrespiration

0.918

TRC10-150 ug/mL Triclosanrespiration

0.152

TRZ10-25 ug/mL Thioridazinerespiration

-0.978

Valinomycin0.5-10 uM Valinomycinrespiration

0.696

ZnSO42 mM ZnSO4respiration

-1.625

menadione6-10 ug/mL Menadionerespiration

0.376

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.184

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.389

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.231

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.105

NRP_1Non-replicating persistence stage 1dosRassociated

-0.227

Amp0.2mg/mL AmpicillincellWall

-0.432

Cephalexin20-100 ug/mL CephalexincellWall

-0.357

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.230

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.481

EMB10-20 ug/mL EthambutolcellWall

-0.735

Eta12-40 ug/mL EthionamidecellWall

-0.790

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.762

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.050

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.831

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.356

BZA0.12 mg/mL BenzamidearomaticAmides

0.301

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.358

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.735

H2O24 mM hydrogen peroxideDNAdamaging

-0.632

Levo10 ug/mL LevofloxacinDNAdamaging

-0.866

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.416

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.889

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.424

UVUV-irradiationDNAdamaging

-1.022

ARP41-4 ug/mL Antitubercular compound ARP4?

5.469

Antimycin12.5-50 ug/mL Antimycin A?

-0.254

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.163

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.146

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.107

PA8240.2-2 ug/mL PA-824?

0.465

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.169

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.291

Verapamil50 uM Verapamil?

0.520

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.136

methoxatin10-20 ug/mL Methoxatin?